The most clearly positive part of this quarter was the Americas. Revenue edged up only about 1% year-over-year to $949 million, but operating profit jumped 22% to $165 million. The fact that earnings rose while revenue was flat means the company is not selling more product — it is simply spending less to make it, and pocketing the difference. The margin (the share of revenue that turns into profit) climbed to 17.4%.

Behind that performance is the company's ongoing cost-reduction program, Fit to Win. In this quarter alone, the program delivered $65 million in total savings — roughly $50 million even after stripping out the impact of plant disruptions — bringing year-to-date cumulative savings to $115 million ($85 million on a net basis). The company reiterated its targets of approximately $200 million in 2026 savings and at least $650 million in cumulative savings over three years.

In other words, within the areas the company can control — namely, improving its cost structure — execution is tracking the plan. The problem, as we will see below, is that Europe and the market environment have more than offset those gains.

The most painful spot is Europe. Revenue declined 5% to $704 million, and operating profit shrank to just $6 million. On a margin basis, that is 0.9% — meaning the company earned barely a penny on every $100 of sales. Competitive pricing pressure, elevated energy costs, and temporary production disruptions tied to restructuring and two furnace accidents all converged at once.

The accounting picture is even more dramatic. A goodwill impairment charge of $873 million was recognized. Goodwill impairment is the write-down of the carrying value of a business acquired in the past when it no longer meets expected value — it is a non-cash charge, meaning no cash actually leaves the company. On top of that, a $96 million valuation allowance was taken against Europe-related deferred tax assets, bringing the net loss to $6.33 per share. While this is not a cash outflow, the fact that management itself has marked down the future earnings power of its European business carries significant weight.

Guidance was lowered alongside these results. 2026 adjusted EBITDA was reset to $1.0–1.1 billion, the 2027 target was cut from $1.45 billion to $1.2–1.3 billion, and this year's free cash flow (the cash left over from operations after investing) is now expected to be a net outflow of $50–$150 million. For a company with a market cap of roughly $1.4 billion, the prospect of cash being a net drain is a point worth watching closely alongside the debt burden. The market reacted immediately, pushing the stock from $9.06 to $7.77 in after-hours trading, a roughly 14% drop.

In this quarter's earnings materials, management attributed Europe's weakness to competitive pricing pressure, elevated energy costs, and temporary operational disruptions tied to restructuring and furnace accidents. In the Americas as well, a single furnace accident constrained shipments by approximately 2%, though the company noted that the impact was largely resolved by July. In short, management framed a significant portion of the disappointment as "transitory."

However, the company's actual actions are more cautious than that explanation suggests. If the issues were truly transitory, there would be no reason to also lower the 2027 target. The decision to reset the 2027 adjusted EBITDA target from $1.45 billion to $1.2–$1.3 billion signals that management itself has accepted the view that Europe's pricing and energy environment will not normalize in the near term. Conversely, holding the Fit to Win savings target steady signals that, even amid a tough market environment, the self-help plan is tracking to plan. Specific commentary from management is expected on the earnings call scheduled for 8:00 a.m. Eastern Time on July 29.

For investors, the actual triggers in this release were not the headline $972 million net loss but rather the fact that adjusted EPS came in at roughly one-third of expectations and that guidance was cut for two consecutive years. The reaction was immediate: shares plunged roughly 14.2% in after-hours trading, from the regular-session close of $9.06 to $7.77. An impairment charge is a non-cash accounting item that the company can write off once and move past, but a profit-guidance cut pulls down expectations for every quarter that follows. With the market cap now down to roughly $1.4 billion, the prospect of negative free cash flow this year is likely to revive questions about the balance sheet's flexibility.

On the other hand, the fact that the Americas lifted operating profit 22% purely through cost reductions offers a useful clue to the potential recovery magnitude if Europe normalizes. Ultimately, the path forward for this stock can be summed up in a single sentence: how quickly can self-help catch up with Europe's structural headwinds.